Skip to content

    Praj Industries Limited

    PRAJIND
    Capital Goods·30 Apr 2025
    Management Summary

    Praj Industries reported a challenging Q4 and FY25 with significant declines in revenue and profitability, primarily due to extended project execution cycles and a slowdown in domestic ethanol orders post-EBP 20. However, the company is strategically positioning for future growth through new partnerships for PLA production, a CBG joint venture with BPCL, and the operationalization of its GenX facility. A robust order backlog and diversification into international markets and co-product solutions are expected to drive recovery and growth in FY26.

    Highlights

    5
    • Q4 FY25 order intake of ₹10,320 million, showing continued business momentum.

    • Order backlog of ₹42,930 million as of March 2025 provides strong revenue visibility for the next 12-15 months.

    • Strategic partnership with Uhde Inventa-Fischer for end-to-end PLA production solutions opens new growth avenues.

    • GenX Mangalore facility commenced operations and secured long-term framework agreements with three customers, poised for FY26 contribution.

    • Healthy growth in services business with order book doubling YoY, and increasing traction in biogenic CO2 capture and fermentation solutions.

    Concerns

    5
    • Consolidated income from operations for Q4 FY25 declined by 20% YoY to ₹8,000 million from ₹10,000 million in Q4 FY24.

    • PBT for Q4 FY25 significantly decreased by 41.75% YoY to ₹582.51 million from ₹1,000 million in Q4 FY24.

    • PAT for Q4 FY25 saw a substantial decline of 56.7% YoY to ₹398.169 million from ₹919.36 million in Q4 FY24.

    • Project execution cycles have extended by almost 12 months due to liquidity challenges and stringent approval processes from funding agencies.

    • The engineering segment's order intake for FY25 decreased by 17% YoY, and its revenue in Q4 FY25 decreased by 30% YoY.

    What Changed1

    vs Q1 FY26

    Guidance items6 → 5 (-1)
    Key financials

    Metrics

    6

    Periods

    2

    Q4 FY25

    3
    • Revenue
      8,000 Mn
      YoY-20%
    • PBT
      582.51 Mn
      YoY-41.8%
    • PAT
      398.169 Mn
      YoY-56.7%

    FY25

    3
    • Revenue
      32,280 Mn
      YoY-6.9%
    • PBT
      2,703 Mn
      YoY-28.4%
    • PAT
      2,189 Mn
      YoY-22.7%

    Segment breakdown

    Bioenergy (FY25 Revenue Mix)
    70% Share of Total Revenue
    Engineering (FY25 Revenue Mix)
    20% Share of Total Revenue
    PHS Business (FY25 Revenue Mix)
    10% Share of Total Revenue
    List

    Order Book

    high confidence

    Total Value

    ₹ 42,930 million

    as of 2025-03-31

    quantified

    Inflow this qtr

    ₹ 10,320 million

    Execution

    Execution cycle for most orders is in the range of 12 to 15 months, with some international engineering orders up to 18-24 months.

    Composition

    Mix6 segments
    • Bioenergy (Backlog)77.0%
    • Engineering (Backlog)18.0%
    • PHS Business (Backlog)5.0%
    • Bioenergy (Q4 Inflow)70.0%
    • Engineering (Q4 Inflow)21.0%
    • PHS Business (Q4 Inflow)9.0%

    Share of order book by segment · partial disclosure (200.0% of book)

    Cancellations / Deferrals

    • deferred:Project execution cycles extended by almost 12 months due to liquidity challenges and stringent approval processes from funding agencies.
    • deferred:Kandla facility is blocked for the next 18 months, leading to inability to take new orders there.
    • deferred:Order intake time mismatch for exports impacted revenue in Q4.

    "Management expects order book to translate into revenue, but execution cycles are longer due to external factors and internal readiness for new facilities."

    Source:
    Prepared remarks

    Capital allocation

    4
    high confidence
    CategoryHeadline
    Dividend

    ₹6/share (final)

    M&A

    Uhde Inventa-Fischer (UIF)

    joint venture · announced

    M&A

    BPCL

    joint venture · signed

    Liquidity

    Cash ₹6,000 million

    Guidance & targets

    4
    CategoryTargetPriority
    Revenue
    GenX Revenue Contribution
    contribute to group revenue
    High
    Revenue
    GenX Break-even Revenue
    Rs. 400-450 crores
    High
    Profitability
    GenX PBT Contribution
    contribute to group PBT
    High
    Revenue Mix
    Domestic vs. International Revenue
    50-50
    Medium

    GenX Order Inflow & Revenue Contribution

    Next quarter (Q1 FY26) and Q2 FY26
    CurrentScale-up related expenditure of ₹76 crores in FY25; Mangalore facility audited and approved by 8 customers, 3 long-term agreements signed.
    TargetQuantified order inflow and initial revenue contribution from GenX.

    Why it matters

    GenX is a new business segment expected to contribute to group revenue and PBT from FY26, crucial for diversification and growth.

    Praj GenX commenced operations at its Mangalore facility in March 2024. During the Financial Year '25, the Mangalore facility was audited and approved by eight key customers. Three customers have already signed a long-term framework agreement for the supply of goods and services. ... With requisite client approvals now secured, GenX is geared up to contribute to group revenue and PBT from FY '25-'26.

    How to verify

    order_book.inflow_this_quarter and key_financials.segment_breakdown

    Risks & concerns

    5
    RiskSeverity

    Liquidity challenges and stringent approval processes for project financial closure

    Leading to extension of average execution cycles by almost 12 months.Management acknowledged

    medium

    Uncertainty regarding final US tariff rates

    New tariff announced at 26% (reduced to 10% for 90 days), but final rate is unknown, though customers bear the duty.Management acknowledged

    medium

    Need for CBG ecosystem streamlining

    Requires more developers and a completely streamlined off-take ecosystem.Management acknowledged

    low

    Order intake time mismatch for exports

    Caused some revenue impact in Q4 FY25 due to orders starting late.Management acknowledged

    low

    Tighter liquidity and money disbursement norms from financing organizations

    Affecting domestic projects and stretching project cycles.Management acknowledged

    medium

    Q&A highlights

    8

    “Our other expenses have a major component of site expenses which are meant for putting up of a project at the customer site. In this quarter, the site activity was on the higher side, especially because we are now constructing the CBG plants, which has major components on the site activity as compared to the materials which are involved in the normal equipment business.”

    Clarifies the reason for higher 'other expenses' in Q4, attributing it to increased site activity for CBG projects, which impacts margin calculation.

    asked by Mohit Kumar

    3 min read8 chapters

    Detailed Narrative

    01

    Q4 & FY25 Financial Performance Overview

    Praj Industries reported a consolidated income from operations of ₹8,000 million in Q4 FY25, a 20% decline from ₹10,000 million in Q4 FY24. PBT for the quarter stood at ₹582.51 million, down 41.75% YoY, and PAT was ₹398.169 million, a 56.7% YoY decrease. For the full year FY25, income from operations was ₹32,280 million, down 6.87% from ₹34,662.78 million in FY24, with PBT at ₹2,703 million (down 28.37%) and PAT at ₹2,189 million (down 22.73%). The company noted a 2.3% margin improvement over Q3 FY25 after considering material and direct expenses.

    02

    Strategic Partnerships & New Business Avenues

    Praj has partnered with Uhde Inventa-Fischer (UIF) to offer end-to-end solutions for PLA production, covering feedstock conversion to lactide and polymerization. This collaboration positions Praj in the biopolymer market. Additionally, a term sheet has been signed with BPCL to develop 10 CBG projects, with regulatory approvals and formal JV formation as the next steps. These initiatives are expected to diversify Praj's offerings and tap into emerging bioeconomy segments.

    03

    Domestic Bioenergy Outlook & Co-products

    India has achieved its EBP 20 target ahead of schedule, and Praj is geared to support future blending mandates. The company's technology team is focused on enhancing customer margins through co-products like Distillers corn oil, rice protein, and high protein DDGS, which are gaining traction among ethanol producers. These patented technologies are expected to significantly alter the financial viability of bioenergy projects and differentiate Praj in the market.

    04

    International Bioenergy & Market Expansion

    Praj is seeing a strong inquiry pipeline from the Americas (Brazil, Argentina, Paraguay) for bioenergy projects, strengthening its presence with local resources. The anticipated 45Z draft notification in the US, expected by October 2025, is poised to create a significant pipeline for low-carbon ethanol opportunities. During Q4 FY25, Praj secured a significant contract from a customer in Paraguay to set up an ethanol plant based on starchy feedstock.

    05

    Engineering Business (GenX) Update

    Praj GenX commenced operations at its Mangalore facility in March 2024. The facility was audited and approved by eight key customers, with three already signing long-term framework agreements. Scale-up related expenditure totaling ₹76 crores impacted FY25 PBT. With client approvals secured, GenX is expected to contribute to group revenue and PBT from FY26, with break-even revenue projected at ₹400-450 crores. The Kandla facility is currently blocked for 18 months, shifting focus to Mangalore for new orders.

    06

    CBG Business Developments

    The CBG segment is witnessing increasing traction, particularly with the BPCL JV and the development of Bio-bitumen technology. Praj achieved a record commissioning of a CBG project in 60 days, demonstrating leadership in the segment. Bio-bitumen, a by-product from waste stream processing, significantly enhances the viability of CBG plants. Mandatory 5% blending in the grid from January next year is expected to further drive demand and infrastructure development for CBG.

    07

    R&D Center Fire Incident

    A fire incident occurred on March 28, 2025, at the office block of Praj Matrix, the R&D center in Pune. Fortunately, there were no casualties or major damage, and R&D operations were unaffected. The fire-impacted office block area is undergoing refurbishment and is expected to be ready in two months, with no financial loss due to insurance coverage.

    08

    Board Changes and Governance

    The Board of Directors requested Dr. Pramod Chaudhari to accept the role of Executive Chairmanship for the next five years, effective July 1, 2025, which he accepted. He will also serve as Founder, Chairman, and Group Mentor. Additionally, Mr. Parth Chaudhari, son of Dr. Pramod Chaudhari, has been approved as a Non-Executive, Non-Independent Director, effective from the next AGM.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.